Genetic tests provide actionable results and guide
important and time sensitive health decisions
Everyone responds to
medications differently
Admera’s PGxOne™ Plus, is a test to help physicians select the best treatments for their patients based on genetics
Over 50 genes | Over 200 variants | Over 300 drugs | Over 310 medical conditions
Everyone responds to
medications differently
Admera’s PGxOne™ Plus, is a test to help physicians select the best treatments for their patients based on genetics
Over 50 genes | Over 200 variants | Over 300 drugs | Over 310 medical conditions
Everyone responds to medications differently
Admera’s PGxOne™ Plus, is a test to help physicians select the best treatments for their patients based on genetics
Over 50 genes | Over 200 variants | Over 300 drugs | Over 310 medical conditions
What is Pharmacogenomics?
Pharmacogenomics (PGx) combines the
study of genetics with the science of
drug delivery. Testing can help predict how
a patient may respond to drug therapy
based on their DNA.
Learn More >
PGxOne™ Plus provides actionable reporting.
The PGxOne™ Plus report is driven by your patient’s diagnosis codes and current medication list allowing for rapid implementation of treatment recommendations.
Learn More >
What is Pharmacogenomics?
Pharmacogenomics (PGx) combines the study of genetics with the science of drug delivery. Testing can help predict how a patient may respond to drug therapy based on their DNA.
Learn More >
PGxOne™ Plus provides actionable reporting.
The PGxOne™ Plus report is driven by your patient’s diagnosis codes and current medication list allowing for rapid implementation of treatment recommendations.
Learn More >
PGxPsych™ is a pharmacogenomics test report tailored for psychiatrists
Achieve desired outcomes quickly
by reducing trial-and-error prescribing
Make medical decisions based on the
highest level of PGx evidence
Effectively manage pain and other comorbidities
PGxPsych™ is a pharmacogenomics test report tailored for psychiatrists
Achieve desired outcomes quickly
Make medical decisions based on the highest level of PGx evidence
Effectively manage pain and other comorbidities
PGxOnco™ is a tailored pharmacogenomics test report providing patient management solutions for the comprehensive oncology practice
Improve patient outcomes and quality of life
by addressing supportive care
Reduce the toxic effects of chemotherapeutics
Increase practice efficiencies
Reduce hospital admissions and contain costs
PGxOnco™ is a pharmacogenomics test providing patient management solutions
for the comprehensive oncology practice
Reduce time addressing supportive care issues
by addressing supportive care
Reduce the toxic effects of chemotherapeutics
Increase practice efficiencies
Reduce hospital admissions and contain costs
LiquidGx
Non-invasive cancer testing for identifying
actionable mutations and treatment
monitoring from a blood sample.
Learn More >
Solid Tumor Profiling
Tumor profiling for targeted therapy selection. Choose between a panel aligned with national treatment guidelines or a comprehensive panel.
Learn More >
LiquidGx
Non-invasive cancer testing for identifying actionable mutations and treatment monitoring from a blood sample.
Learn More >
Solid Tumor Profiling
Tumor profiling for targeted therapy selection. Choose between a panel aligned with national treatment guidelines or a comprehensive panel.
Learn More >
PGxCardio™ is a pharmacogenomics test report that helps guide treatment of a leading cause of morbidity and death
Can be utilized as a stand alone test or paired with the AtheroGxOne™ and CardioGxOne™
PGxCardio™ is a pharmacogenomics test that helps predict how a patient will respond to cardiovascular drug therapy
Guide effective treatment decisions and potentially reduce adverse drug events
Can be utilized as a stand alone test or paired with the AtheroGxOne™ and CardioGxOne™
AtheroGxOne™
Detects genetic variants responsible
for diseases that can cause early
atherosclerosis.
Learn More >
CardioGxOne™
Detects genetic variants responsible for over 30 inherited cardiovascular diseases included cardiomyopathies, arrhythmias, and aortic vascular diseases.
Learn More >
AtheroGxOne™
Detects genetic variants responsible for diseases that can cause early atherosclerosis.
Learn More >
CardioGxOne™
Detects genetic variants responsible for over 30 inherited cardiovascular diseases included cardiomyopathies, arrhythmias, and aortic vascular diseases.
Learn More >
1
Provide a buccal swab,
mouth wash, blood,
saliva sample, or FFPE*
*FFPE material is needed for
solid tumor profiling.
2
Ship the
specimen to
Admera Health
3
Admera Health
scientists sequence
and interpret DNA
4
Receive a
personalized
genetic report
